Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D3 Supplementation for Heart Failure
NCT01636570Phase 2Completed
- Start
- Aug 2012
- Primary completion
- Apr 2015
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in heart failure (HF) comparing Vitamin D3 with Placebo (2 arms). Primary endpoint: B-type Natriuretic Peptide at 6 months. Started Aug 2012; status: completed.
02
Drugs
vitamin d
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT01636570.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01636570.